Kathryn DiMarco - 09 Feb 2023 Form 4 Insider Report for Organon & Co. (OGN)

Role
Corporate Controller
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Kathryn DiMarco
Issuer symbol
OGN
Transactions as of
09 Feb 2023
Net transactions value
-$21,963
Form type
4
Filing time
10 Feb 2023, 17:04:55 UTC
Previous filing
11 May 2022
Next filing
04 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise $0 +1,869 +68% $0.000000 4,615 09 Feb 2023 Direct F1
transaction OGN Common Stock Tax liability $21,963 -740 -16% $29.68 3,875 09 Feb 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Options Exercise $0 -1,869 -50% $0.000000 1,869 09 Feb 2023 Common Stock 1,869 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU.
F2 The amount of the RSUs has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations.
F3 On each of February 9, 2022 and February 9, 2023, one-third of the RSUs vested with the remaining RSUs to vest on February 9, 2024.